How the Pharmaceutical Industry is Tackling Scope 3 Emissions

The Energize supply chain decarbonization program brings together leading pharmaceutical companies to collaborate on reducing their Scope 3 emissions and mitigating the overall environmental impact of the pharmaceutical industry. By working with Schneider Electric and other leading pharmaceutical companies, Energize aims to assist pharmaceutical suppliers in adopting renewable energy by providing education and removing market barriers.

In this video, representatives from two pharmaceutical companies participating in this program, GSK and Novartis, talk about the goal of the program and the potential for this model to be scaled to other sectors.

Previous Article
Schneider Electric Announces Additional Participation in First-of-its-Kind Supplier Program to Advance Climate Action
Schneider Electric Announces Additional Participation in First-of-its-Kind Supplier Program to Advance Climate Action

Amgen and Bristol Myers Squibb join ten other pharmaceutical companies to help accelerate the adoption of r...

Next Article
Energize Round Table: Pharmaceutical Supply Chain Collaboration
Energize Round Table: Pharmaceutical Supply Chain Collaboration

Schneider Electric hosts a roundtable with several participating companies in the Energize pharmaceutical s...

VIDEO

How & Why Business Leaders are Collaborating on Scope 3

Watch Now